This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
The effectiveness of Vaxzevria and CoronaVac vaccines: A nationwide longitudinal retrospective study of 61 million Brazilians (VigiVac-COVID19)
Preprint
in English
| Fiocruz Preprints
| ID: ppf-48821
Full text:
Available
Collection:
Preprints
Database:
Fiocruz Preprints
Country/Region as subject:
South America
/
Brazil
Language:
English
Year:
2021
Document type:
Preprint
